Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
45.54
+0.47 (1.04%)
At close: Sep 26, 2025, 4:00 PM EDT
45.87
+0.33 (0.72%)
After-hours: Sep 26, 2025, 6:08 PM EDT
Sanofi Stock Forecast
Stock Price Forecast
The 2 analysts that cover Sanofi stock have a consensus rating of "Buy" and an average price target of $61.5, which forecasts a 35.05% increase in the stock price over the next year. The lowest target is $58 and the highest is $65.
Price Target: $61.5 (+35.05%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Sanofi stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 0 | 1 |
Buy | 0 | 0 | 0 | 0 | 1 | 2 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $56 → $58 | Hold → Buy | Upgrades | $56 → $58 | +27.36% | Sep 8, 2025 |
Deutsche Bank | Deutsche Bank | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Sep 2, 2025 |
JP Morgan | JP Morgan | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Aug 8, 2025 |
Goldman Sachs | Goldman Sachs | Hold Initiates $65 | Hold | Initiates | $65 | +42.73% | Mar 21, 2025 |
Argus Research | Argus Research | Strong Buy Maintains $55 → $60 | Strong Buy | Maintains | $55 → $60 | +31.75% | Jul 26, 2024 |
Financial Forecast
Revenue This Year
44.96B
from 44.29B
Increased by 1.53%
Revenue Next Year
48.14B
from 44.96B
Increased by 7.06%
EPS This Year
8.00
from 4.44
Increased by 80.07%
EPS Next Year
8.68
from 8.00
Increased by 8.51%
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 49.1B | 52.5B | |||
Avg | 45.0B | 48.1B | |||
Low | 42.1B | 45.1B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 10.8% | 16.7% | |||
Avg | 1.5% | 7.1% | |||
Low | -4.9% | 0.2% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 9.50 | 9.53 | |||
Avg | 8.00 | 8.68 | |||
Low | 7.25 | 7.69 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 114.0% | 19.2% | |||
Avg | 80.1% | 8.5% | |||
Low | 63.2% | -3.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.